2007 NSTI Nanotechnology Conference and Trade Show - Nanotech 2007 - 10th Annual

Alnis BioSciences, Inc.

S. Barry
Alnis BioSciences, Inc., US

Pharma & Biotech

Proprietary MagNaGelâ„¢ nanoparticles approximate the size and tumor-targeting capabilities of monoclonal antibodies. The nanoparticles are also comprised of magnetic crystals, enabling use as MRI diagnostic agents. Additionally, the magnetic core can be energized to increase particle penetration into tumors and to release a chemotherapeutic payload.

Back to Program

Sessions Sunday Monday Tuesday Wednesday Thursday Authors Keywords

Nanotech 2007 Conference Program Abstract


Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.